SPORANOX ® (Itraconazole) Oral Solution Congestive Heart Failure: When itraconazole was administered intravenously to dogs and healthy human volunteers, negative inotropic effects were seen.
SPORANOX ® Capsules Itraconazole Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about SPORANOX capsules.
Antifungal Agents Lamisil ® (terbinafine), Sporanox ® (itraconazole), Penlac ® (ciclopirox), Vfend ® (voriconazole), Oravig ® (miconazole) Effective Date: 12/1/10 Original Policy Date: 10/17/00 Committee Review Date: 10/17/00, 9/18/01, 9/24/02, 1/7/03, 1/20/04, 1/18/05, 10/15/06, 11/5/07 ...
Drug Therapy Guidelines: Lamisil ® (terbinafine), Sporanox ® (itraconazole), Penlac ® (ciclopirox) NF, Vfend ® (voriconazole) Effective Date: 11/20/07 Committee Review Date: 10/17/00, 9/18/01, 9/24/02, 1/7/03, 1/20/04, 1/18/05, 10/15/06, 11/5/07 Policy Statements: Non-Formulary or Prior ...
DESCRIPTION SPORANOX ® is the brand name for itraconazole, a synthetic triazole antifungal agent. Itraconazole is a 1:1:1:1 racemic mixture of four diastereomers (two enantiomeric pairs), each possessing three chiral centers.
SPORANOX ® Oral Solution Itraconazole Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about SPORANOX Oral Solution.
SPORANOX ® (itraconazole) Oral Solution Congestive Heart Failure: When itraconazole was administered intravenously to dogs and healthy human volunteers, negative inotropic effects were seen.
(Sporanox ®)] as medically necessary for treatment of superficial fungal infections for ANY of the following indications: • tinea corporis • tinea cruris
SPORANOX ® (itraconazole) Capsules Congestive Heart Failure: SPORANOX ® (itraconazole) Capsules should not be administered for the treatment of onychomycosis in patients with evidence of ventricular dysfunction such as congestive heart failure (CHF) or a history of CHF .
Volume 7 • Supplement 1 •2002 Itraconazole (Sporanox ®, Janssen Pharmaceuticals) is a triazole with fungistatic activity against Candida species, particularly C. albicans .